230 related articles for article (PubMed ID: 36281973)
21. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
22. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.
Chrysavgis L; Ztriva E; Protopapas A; Tziomalos K; Cholongitas E
World J Gastroenterol; 2020 Nov; 26(42):6514-6528. PubMed ID: 33268944
[TBL] [Abstract][Full Text] [Related]
23. Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease.
Jiang Y; Zhuang X; Zhang J; Li M; Du S; Tian J; Yuan Y; Ji G; Hu C
Front Endocrinol (Lausanne); 2023; 14():1171397. PubMed ID: 38034020
[TBL] [Abstract][Full Text] [Related]
24. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e529-e534. PubMed ID: 33867441
[TBL] [Abstract][Full Text] [Related]
25. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
26. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
Du T; Yu X; Yuan G; Zhang J; Sun X
Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women.
Cho Y; Chang Y; Choi HR; Kang J; Kwon R; Lim GY; Ahn J; Kim KH; Kim H; Hong YS; Zhao D; Rampal S; Cho J; Park HY; Guallar E; Ryu S
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889762
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Souza M; Diaz I; Barchetta I; Mantovani A
Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
[TBL] [Abstract][Full Text] [Related]
29. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank.
Chahal D; Sharma D; Keshavarzi S; Arisar FAQ; Patel K; Xu W; Bhat M
Hepatol Int; 2022 Apr; 16(2):325-336. PubMed ID: 35178663
[TBL] [Abstract][Full Text] [Related]
30. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
[TBL] [Abstract][Full Text] [Related]
31. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
[TBL] [Abstract][Full Text] [Related]
32. Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.
Bernhardt P; Kratzer W; Schmidberger J; Graeter T; Gruener B;
BMC Res Notes; 2018 Feb; 11(1):101. PubMed ID: 29409538
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
Kim Y; Han E; Lee JS; Lee HW; Kim BK; Kim MK; Kim HS; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Lee YH; Kim SU
Gut Liver; 2022 Mar; 16(2):290-299. PubMed ID: 34238770
[TBL] [Abstract][Full Text] [Related]
34. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
35. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
36. Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities.
Wijarnpreecha K; Li F; Lundin SK; Suresh D; Song MW; Tao C; Chen VL; Lok ASF
Aliment Pharmacol Ther; 2023 May; 57(9):1014-1027. PubMed ID: 36815445
[TBL] [Abstract][Full Text] [Related]
37. Association of genetic variations with NAFLD in lean individuals.
Lin H; Wong GL; Whatling C; Chan AW; Leung HH; Tse CH; Shu SS; Chim AM; Lai JC; Yip TC; Wong VW
Liver Int; 2022 Jan; 42(1):149-160. PubMed ID: 34610207
[TBL] [Abstract][Full Text] [Related]
38. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
Niriella MA; Kasturiratne A; Pathmeswaran A; De Silva ST; Perera KR; Subasinghe SKCE; Kodisinghe SK; Piyaratna TACL; Vithiya K; Dassanayaka AS; De Silva AP; Wickramasinghe AR; Takeuchi F; Kato N; de Silva HJ
Hepatol Int; 2019 May; 13(3):314-322. PubMed ID: 30539516
[TBL] [Abstract][Full Text] [Related]
39. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.
Yun Y; Kim HN; Lee EJ; Ryu S; Chang Y; Shin H; Kim HL; Kim TH; Yoo K; Kim HY
PLoS One; 2019; 14(3):e0213692. PubMed ID: 30870486
[TBL] [Abstract][Full Text] [Related]
40. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities.
Golabi P; Paik JM; Arshad T; Younossi Y; Mishra A; Younossi ZM
Hepatol Commun; 2020 Aug; 4(8):1136-1148. PubMed ID: 32766474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
